NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

None of this not picking, will help you prove something a court conclusively indicated did not happen. The next opportunity was the 2017 interim analysis review, which was published and still blinded.

And also the court conclusively said even if the DSMB would have done an efficacy review, which the court said they had not, the company would STILL be blinded.